A detailed history of Geode Capital Management, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,094,644 shares of CABA stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,094,644
Previous 970,573 12.78%
Holding current value
$3.2 Million
Previous $7.26 Million 28.83%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.94 - $8.24 $488,839 - $1.02 Million
124,071 Added 12.78%
1,094,644 $5.17 Million
Q2 2024

Aug 09, 2024

BUY
$7.22 - $18.82 $1.43 Million - $3.72 Million
197,483 Added 25.54%
970,573 $7.26 Million
Q1 2024

May 13, 2024

BUY
$16.79 - $25.38 $334,356 - $505,417
19,914 Added 2.64%
773,090 $13.2 Million
Q4 2023

Feb 13, 2024

BUY
$12.21 - $23.36 $748,521 - $1.43 Million
61,304 Added 8.86%
753,176 $17.1 Million
Q3 2023

Nov 13, 2023

BUY
$11.84 - $18.65 $2.24 Million - $3.53 Million
189,145 Added 37.62%
691,872 $10.5 Million
Q2 2023

Aug 11, 2023

BUY
$7.65 - $13.95 $2.16 Million - $3.95 Million
282,877 Added 128.67%
502,727 $6.49 Million
Q1 2023

May 15, 2023

SELL
$7.08 - $12.62 $80,818 - $144,057
-11,415 Reduced 4.94%
219,850 $1.82 Million
Q4 2022

Feb 13, 2023

BUY
$0.64 - $9.3 $65,142 - $946,600
101,785 Added 78.61%
231,265 $2.14 Million
Q2 2022

Aug 12, 2022

BUY
$0.99 - $2.11 $6,806 - $14,506
6,875 Added 5.61%
129,480 $137,000
Q1 2022

May 13, 2022

SELL
$1.68 - $3.92 $1 - $3
-1 Reduced -0.0%
122,605 $248,000
Q4 2021

Feb 11, 2022

BUY
$3.36 - $14.64 $13,325 - $58,062
3,966 Added 3.34%
122,606 $464,000
Q3 2021

Nov 12, 2021

BUY
$7.0 - $12.5 $6,846 - $12,225
978 Added 0.83%
118,640 $1.44 Million
Q2 2021

Aug 13, 2021

SELL
$7.2 - $11.73 $608,270 - $990,973
-84,482 Reduced 41.79%
117,662 $1.01 Million
Q1 2021

May 12, 2021

BUY
$10.39 - $14.53 $268,436 - $375,397
25,836 Added 14.65%
202,144 $2.24 Million
Q4 2020

Feb 12, 2021

BUY
$9.81 - $15.8 $96,657 - $155,677
9,853 Added 5.92%
176,308 $2.2 Million
Q3 2020

Nov 13, 2020

SELL
$9.71 - $14.41 $177,158 - $262,910
-18,245 Reduced 9.88%
166,455 $1.8 Million
Q2 2020

Aug 13, 2020

BUY
$6.39 - $11.28 $233,183 - $411,629
36,492 Added 24.62%
184,700 $2.06 Million
Q1 2020

May 14, 2020

BUY
$6.0 - $18.67 $224,604 - $698,892
37,434 Added 33.79%
148,208 $1.08 Million
Q4 2019

Feb 13, 2020

BUY
$7.88 - $17.71 $872,899 - $1.96 Million
110,774 New
110,774 $1.55 Million

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $84.7M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.